Occudo Quantitative Strategies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,814
Closed -$488K 1401
2021
Q4
$488K Sell
22,814
-47,279
-67% -$932K 0.04% 619
2021
Q3
$1.29M Buy
70,093
+57,267
+446% +$1.15M 0.16% 187
2021
Q2
$275K Buy
+12,826
New +$261K 0.04% 636

Other funds holding OCDX

Occudo Quantitative Strategies's OCDX Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 22,814 shares — an estimated $488K sold.

Occudo Quantitative Strategies first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $1.29M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 22,814 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $488K.
  • Occudo Quantitative Strategies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.29M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.